newsfilter
← Latest News
GlobeNewswire·

Alaunos Therapeutics Appoints Dr. Robert J. Hofmeister to Board of Directors

HOUSTON, March 30, 2023 (GLOBE NEWSWIRE) -- Alaunos Therapeutics, Inc. ("Alaunos" or the "Company") (NASDAQ:TCRT), a leading T-cell receptor (TCR) cell therapy company advancing a clinical-stage pipeline of